{"id":"https://openalex.org/W2890917067","doi":"https://doi.org/10.1016/j.ymthe.2018.09.005","title":"RNAi-Mediated \u03b2-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade","display_name":"RNAi-Mediated \u03b2-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade","publication_year":2018,"publication_date":"2018-09-13","ids":{"openalex":"https://openalex.org/W2890917067","doi":"https://doi.org/10.1016/j.ymthe.2018.09.005","mag":"2890917067","pmid":"https://pubmed.ncbi.nlm.nih.gov/30274786","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6225018"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2018.09.005","doi":"https://doi.org/10.1016/j.ymthe.2018.09.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2018.09.005","pdf_url":"http://www.cell.com/article/S1525001618304465/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001618304465/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085330447","display_name":"Shanthi Ganesh","orcid":"https://orcid.org/0000-0001-9278-0865","observed_orcids":["https://orcid.org/0000-0001-9278-0865"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shanthi Ganesh","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA. Electronic address: sganesh@dicerna.com","Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA. Electronic address: sganesh@dicerna.com","institution_ids":["https://openalex.org/I4210143007"]},{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068167167","display_name":"Xue Shui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xue Shui","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043853532","display_name":"Kevin P. Craig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin P. Craig","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100392578","display_name":"Jihye Park","orcid":"https://orcid.org/0000-0002-4451-2046","observed_orcids":["https://orcid.org/0000-0002-4451-2046"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jihye Park","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100331948","display_name":"Weimin Wang","orcid":"https://orcid.org/0000-0002-4531-835X","observed_orcids":["https://orcid.org/0000-0002-4531-835X"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weimin Wang","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103975901","display_name":"Bob D. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bob D. Brown","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029964675","display_name":"Marc T. Abrams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc T. Abrams","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc., Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I4210143007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085330447"],"corresponding_institution_ids":["https://openalex.org/I4210143007"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":5.5333,"has_fulltext":true,"cited_by_count":117,"citation_normalized_percentile":{"value":0.97796226,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"26","issue":"11","first_page":"2567","last_page":"2579"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.025599999353289604,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.011699999682605267,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.5509999990463257},{"id":"https://openalex.org/keywords/ctnnb1","display_name":"CTNNB1","score":0.9179999828338623},{"id":"https://openalex.org/keywords/wnt-beta-catenin-signaling","display_name":"Wnt/\u03b2-catenin signaling","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7210000157356262},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9440000057220459},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":1.0},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.984000027179718},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.8379999995231628},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5640000104904175},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.6259999871253967},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6349999904632568},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/t-cell-mediated-cytotoxicity","display_name":"T cell cytotoxicity","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7991198301315308},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.6719876527786255},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6186627745628357},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5798400640487671},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5295321345329285},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.511599600315094},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.5079749226570129},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4208899140357971},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28810492157936096},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.146293044090271},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11832746863365173},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09216484427452087},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.08443662524223328},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008546","descriptor_name":"Melanoma, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051155","descriptor_name":"Wnt1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060449","descriptor_name":"Wnt Signaling Pathway","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ymthe.2018.09.005","doi":"https://doi.org/10.1016/j.ymthe.2018.09.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2018.09.005","pdf_url":"http://www.cell.com/article/S1525001618304465/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5798440","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6225018","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6225018","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6225018","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther","raw_type":"Text"},{"id":"pmid:30274786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30274786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2018.09.005","doi":"https://doi.org/10.1016/j.ymthe.2018.09.005","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2018.09.005","pdf_url":"http://www.cell.com/article/S1525001618304465/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2355954828","display_name":"Optimization of a clinical stage nanoparticle drug delivery platform","funder_award_id":"R43CA186410","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3731830588","display_name":"Optimization of a clinical stage nanoparticle drug delivery platform","funder_award_id":"R44CA186410","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5552922704","display_name":null,"funder_award_id":"IR43CA186410-02","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2890917067.pdf","grobid_xml":"https://content.openalex.org/works/W2890917067.grobid-xml"},"referenced_works_count":80,"referenced_works":["https://openalex.org/W1498931318","https://openalex.org/W1862015311","https://openalex.org/W1913780655","https://openalex.org/W1944707476","https://openalex.org/W1974033611","https://openalex.org/W1979401452","https://openalex.org/W1990189227","https://openalex.org/W1994029539","https://openalex.org/W1994993231","https://openalex.org/W1999177893","https://openalex.org/W2002293894","https://openalex.org/W2013447450","https://openalex.org/W2020018765","https://openalex.org/W2033618020","https://openalex.org/W2040956995","https://openalex.org/W2051481113","https://openalex.org/W2054895771","https://openalex.org/W2060070314","https://openalex.org/W2066671159","https://openalex.org/W2074606310","https://openalex.org/W2076378830","https://openalex.org/W2112601576","https://openalex.org/W2114671410","https://openalex.org/W2115001053","https://openalex.org/W2116376943","https://openalex.org/W2116959561","https://openalex.org/W2118486765","https://openalex.org/W2120572492","https://openalex.org/W2127437403","https://openalex.org/W2131989981","https://openalex.org/W2134887638","https://openalex.org/W2143772132","https://openalex.org/W2148805887","https://openalex.org/W2155461614","https://openalex.org/W2157873170","https://openalex.org/W2158157784","https://openalex.org/W2169403180","https://openalex.org/W2172537925","https://openalex.org/W2177971463","https://openalex.org/W2201379305","https://openalex.org/W2257916459","https://openalex.org/W2295526061","https://openalex.org/W2311929452","https://openalex.org/W2338576144","https://openalex.org/W2340636398","https://openalex.org/W2340751952","https://openalex.org/W2418808650","https://openalex.org/W2467025550","https://openalex.org/W2468296498","https://openalex.org/W2490544327","https://openalex.org/W2515812752","https://openalex.org/W2520632143","https://openalex.org/W2531876842","https://openalex.org/W2549056955","https://openalex.org/W2552750859","https://openalex.org/W2560367415","https://openalex.org/W2564433363","https://openalex.org/W2566351456","https://openalex.org/W2587048937","https://openalex.org/W2593870963","https://openalex.org/W2605630275","https://openalex.org/W2610193187","https://openalex.org/W2614467908","https://openalex.org/W2620472170","https://openalex.org/W2624616322","https://openalex.org/W2624920353","https://openalex.org/W2655262992","https://openalex.org/W2737542013","https://openalex.org/W2741047383","https://openalex.org/W2751965733","https://openalex.org/W2765577638","https://openalex.org/W2766477030","https://openalex.org/W2772259326","https://openalex.org/W2772899582","https://openalex.org/W2774935716","https://openalex.org/W2781007106","https://openalex.org/W2782949806","https://openalex.org/W2793126529","https://openalex.org/W2807263356","https://openalex.org/W2909312563"],"related_works":["https://openalex.org/W2740021068","https://openalex.org/W2754744756","https://openalex.org/W2912714535","https://openalex.org/W2886082066","https://openalex.org/W2891249858","https://openalex.org/W6958313734","https://openalex.org/W3081900803","https://openalex.org/W2495019162","https://openalex.org/W4391275727","https://openalex.org/W2741835552"],"abstract_inverted_index":{"Wnt/\u03b2-catenin":[0],"signaling":[1],"mediates":[2],"cancer":[3,42,192],"immune":[4,9,19],"evasion":[5],"and":[6,77,91,111,149],"resistance":[7],"to":[8,36,84,101,116,187,191],"checkpoint":[10,85],"therapy,":[11],"in":[12,40,103,156,171],"part":[13],"by":[14],"blocking":[15],"cytokines":[16],"that":[17,60],"trigger":[18,55],"cell":[20,75],"recruitment.":[21],"Inhibition":[22],"of":[23,81,89,128,140,142,163,174],"\u03b2-catenin":[24,68,181],"may":[25],"be":[26],"an":[27,184],"effective":[28,38,185],"strategy":[29,186],"for":[30],"increasing":[31],"the":[32,58,79,82,117,129,172],"low":[33],"response":[34,189],"rate":[35],"these":[37],"medicines":[39],"numerous":[41],"populations.":[43],"DCR-BCAT":[44,71,90,155],"is":[45],"a":[46,51,160],"nanoparticle":[47],"drug":[48,133],"product":[49],"containing":[50],"chemically":[52],"optimized":[53],"RNAi":[54],"targeting":[56],"CTNNB1,":[57],"gene":[59],"encodes":[61],"\u03b2-catenin.":[62],"In":[63],"syngeneic":[64],"mouse":[65],"tumor":[66,96],"models,":[67],"inhibition":[69,98,182],"with":[70,137,154],"significantly":[72,94],"increased":[73],"T":[74,143],"infiltration":[76],"potentiated":[78],"sensitivity":[80],"tumors":[83],"inhibition.":[86],"The":[87],"combination":[88,119,134],"immunotherapy":[92],"yielded":[93],"greater":[95],"growth":[97],"(TGI)":[99],"compared":[100],"monotherapy":[102],"B16F10":[104],"melanoma,":[105],"4T1":[106],"mammary":[107],"carcinoma,":[108],"Neuro2A":[109],"neuroblastoma,":[110],"Renca":[112],"renal":[113],"adenocarcinoma.":[114],"Response":[115],"RNAi-containing":[118],"therapy":[120],"was":[121,135],"not":[122],"dependent":[123],"on":[124],"Wnt":[125],"activation":[126],"status":[127],"tumor.":[130],"Importantly,":[131],"this":[132],"associated":[136],"elevated":[138],"levels":[139],"biomarkers":[141],"cell-mediated":[144],"cytotoxicity.":[145],"Finally,":[146],"when":[147],"CTLA-4":[148],"PD-1":[150],"antibodies":[151],"were":[152,169],"combined":[153],"MMTV-Wnt1":[157],"transgenic":[158],"mice,":[159],"genetic":[161],"model":[162],"spontaneous":[164],"Wnt-driven":[165],"tumors,":[166],"complete":[167],"regressions":[168],"achieved":[170],"majority":[173],"treated":[175],"subjects.":[176],"These":[177],"data":[178],"support":[179],"RNAi-mediated":[180],"as":[183],"increase":[188],"rates":[190],"immunotherapy.":[193]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":33},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-09-27T00:00:00"}